The effect of NeuroAiD™ (MLC601) on cerebral blood flow velocity in subjects' post brain infarct in the middle cerebral artery territory

Published:February 08, 2011DOI:



      Stroke is the third common cause of mortality and the most common cause of morbidity in adults. MLC601 (NeuroAiD™) is a treatment indicated for post stroke recovery. An increase of impaired cerebral blood flow may be an important parameter for recovery processes. The aim of this study was to investigate the effect of MLC601 on cerebral blood flow velocity as an indirect evidence of cerebral blood flow increase in post stroke subjects.


      This is a double-blinded, placebo controlled, randomized study of 80 subjects included within a week of stroke onset. All subjects were given either MLC601 or placebo, 4 capsules, 3 times a day for 3 months. Cerebral blood flow within the middle cerebral artery, with blood flow velocity measured by transcranial Doppler (TCD), and Barthel index was assessed at baseline and at 3 months.


      The mean change in cerebral blood flow velocity in the MLC601 treatment group (15.9) was significantly increased (p=0.009) compared to the placebo group (9.6). Subjects in the treatment group also showed a significant difference in the mean rank of modified ranking scale (p<0.001) and mean change of the Barthel Index: 36 vs. 29 in the placebo group (p<0.001).


      This is the first study suggesting that treatment with MLC601 may increase cerebral blood flow in stroke subjects. This may be mediated by an effect on stimulating microcirculation, an important process contributing to neuroplasticity in the central nervous system. This effect on cerebral blood flow may be associated with improvement in measures of functional recovery.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Azarpazhooh M.R.
        • Etemadi M.M.
        • Donnan G.A.
        • Mokhber N.
        • Majdi M.R.
        • Ghayour-Mobarhan M.
        • et al.
        Excessive incidence of stroke in Iran: evidence from the Mashhad Stroke Incidence Study (MSIS), a population-based study of stroke in the Middle East.
        Stroke. 2010; 41: e3-e10
        • Hacke W.
        • Kaste M.
        • Bluhmki E.
        Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
        N Engl J Med. 2008; 359: 1317-1329
        • Ghandehari K.
        • Zahed A.
        • Taheri M.
        • Abbasi M.
        • Gorjestani S.
        • Ahmadi A.
        • et al.
        Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.
        Int J Stroke. 2009; 4: 236
        • Lakhan S.E.
        • Kirchgessner A.
        • Hofer M.
        Inflammatory mechanisms in ischemic stroke: therapeutic approaches.
        J Transl Med. 2009; 7: 97
        • Cramer S.C.
        Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery.
        Ann Neurol. 2008; 63: 272-287
        • Li P.
        • Murphy T.H.
        Two-photon imaging during prolonged middle cerebral artery occlusion in mice reveals recovery of dendritic structure after reperfusion.
        J Neurosci. 2008; 28: 11970-11979
        • Zhang S.
        • Murphy T.H.
        Imaging the impact of cortical microcirculation on synaptic structure and sensory-evoked hemodynamic responses in vivo.
        PLoS Biol. 2007; 5: e119
        • Chen C.
        • Venketasubramanian N.
        • Gan R.N.
        • Lambert C.
        • Picard D.
        • Chan B.P.L.
        • et al.
        Danqi Piantang Jiaonang (DJ), a traditional Chinese medicine, in poststroke recovery.
        Stroke. 2009; 40: 859-863
        • Venketasubramanian N.
        • Chen C.L.H.
        • Gan R.N.
        • Chan B.P.L.
        • Chang H.M.
        • Tan S.B.
        • et al.
        A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES Study).
        Int J Stroke. 2009; 4: 54-60
        • Gan R.
        • Lambert C.
        • Lianting J.
        • Chan E.S.Y.
        • Venketasubramanian N.
        • Chen C.
        • et al.
        Danqi Piantan Jiaonang does not modify hemostasis, hematology, and biochemistry in normal subjects and stroke patients.
        Cerebrovasc Dis. 2008; 25: 450-456
        • Young S.H.Y.
        • Zhao Y.
        • Koh A.
        • Singh R.
        • Chan B.P.L.
        • Chang H.M.
        • et al.
        Safety profile of MLC601 (Neuroaid) in acute ischemic stroke patients: a Singaporean substudy of the Chinese medicine neuroaid efficacy on stroke recovery study.
        Cerebrovasc Dis. 2010; 30: 1-6
        • Heurteaux C.
        • Gandin C.
        • Borsotto M.
        • Widmann C.
        • Brau F.
        • Lhuillier M.
        • et al.
        Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo.
        Neuropharmacology. 2010; 58: 987-1001
        • Adams JR., H.P.
        • Bendixen B.H.
        • Kappelle L.J.
        • Biller J.
        • Love B.B.
        • Gordon D.L.
        • et al.
        Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
        Stroke. 1993; 24: 35-41
        • Mahoney F.I.
        • Barthel D.W.
        Functional Evaluation: The Barthel Index.
        Md State Med J. 1965; 14: 61-65
        • Swieten J.C.
        • Koudstaal P.J.
        • Visser M.C.
        • Schouten H.J.
        • Van J.
        Interobserver agreement for the assessment of handicap in stroke patients.
        Stroke. 1988; 19: 604-607
        • Mabuchi T.
        • Kitagawa K.
        • Ohtsuki T.
        • Kuwabara K.
        • Yagita Y.
        • Yanagihara T.
        • et al.
        Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats.
        Stroke. 2000; 31: 1735-1743
        • Moskowitz M.A.
        • Lo E.H.
        • Iadecola C.
        The science of stroke: mechanisms in search of treatments.
        Neuron. 2010; 67: 181-198
        • D'Olhaberriague L.
        • Litvan I.
        • Mitsias P.
        • Mansbach H.H.
        A reappraisal of reliability and validity studies in stroke.
        Stroke. 1996; 27: 2331-2336
        • Alexandrov A.V.
        Practical models of cerebral hemodynamics and waveform recognition.
        in: Alexandrov A.V. Cerebrovascular ultrasound in stroke prevention and treatment. Blackwell, 2007: 62-77
        • Wei L.
        • Erinjeri J.p.
        • Rovainen C.M.
        • Woolsey T.A.
        Collateral growth and angiogenesis around cortical stroke.
        Stroke. 2001; 32: 2179-2184
        • Kong K.H.
        • Wee S.K.
        • Ng C.Y.
        • Chua K.
        • Chan K.F
        • Venketasubramanian N.
        • Chen C.
        A Double-Blind, Placebo-Controlled, Randomized Phase II Pilot Study to Investigate the Potential Efficacy of the Traditional Chinese Medicine Neuroaid (MLC 601) in Enhancing Recovery after Stroke (TIERS).
        Cerebrovasc Dis. 2009; 28: 514-521